PFS
CLVS

Prospera Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Prospera Financial Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,150
Closed -$16K – 1675
2022
Q2 		$16K Buy
9,150
+4,100
+81% +$6.05K ﹤0.01% 1258
2022
Q1 		$10K Buy
+5,050
New +$9.92K ﹤0.01% 2055
2020
Q4 		– Sell
-850
Closed -$5K – 1674
2020
Q3 		$5K Buy
+850
New +$5.09K ﹤0.01% 1307

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prospera Financial Services's CLVS Position: Q3 2022 in Review

Prospera Financial Services sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 9,150 shares — an estimated $16K sold.

Prospera Financial Services first reported a position in CLVS in Q3 2020 and held it in 3 quarters. The position peaked at $16K in Q2 2022. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Prospera Financial Services reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 9,150 Clovis Oncology, Inc. shares in Q3 2022, an estimated $16K.
  • Prospera Financial Services first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 3 quarters.
  • Prospera Financial Services's Clovis Oncology, Inc. position peaked at $16K in Q2 2022.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.